Nishizaki M - Search Results

1

Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent.

Ogawa N, Fujiwara T, Kagawa S, Nishizaki M, Morimoto Y, Tanida T, Hizuta A, Yasuda T, Roth JA, Tanaka N. Ogawa N, et al. Among authors: nishizaki m. Int J Cancer. 1997 Nov 4;73(3):367-70. doi: 10.1002/(sici)1097-0215(19971104)73:3<367::aid-ijc11>3.0.co;2-a. Int J Cancer. 1997. PMID: 9359484

2

[Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].

Fujiwara T, Ogawa N, Kagawa S, Nishizaki M, Yasuda T, Tanaka N, Orita K, Roth JA. Fujiwara T, et al. Among authors: nishizaki m. Gan To Kagaku Ryoho. 1996 Jul;23(8):1085-8. Gan To Kagaku Ryoho. 1996. PMID: 8687228 Japanese. No abstract available.

3

Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer.

Bouvet M, Ellis LM, Nishizaki M, Fujiwara T, Liu W, Bucana CD, Fang B, Lee JJ, Roth JA. Bouvet M, et al. Among authors: nishizaki m. Cancer Res. 1998 Jun 1;58(11):2288-92. Cancer Res. 1998. PMID: 9622060

4

Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.

Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N. Fukazawa T, et al. Among authors: nishizaki m. Oncogene. 1999 Apr 1;18(13):2189-99. doi: 10.1038/sj.onc.1202561. Oncogene. 1999. PMID: 10327065

5

Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.

Nishizaki M, Fujiwara T, Tanida T, Hizuta A, Nishimori H, Tokino T, Nakamura Y, Bouvet M, Roth JA, Tanaka N. Nishizaki M, et al. Clin Cancer Res. 1999 May;5(5):1015-23. Clin Cancer Res. 1999. PMID: 10353734

6

Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.

Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, Yamatsuji T, Nishizaki M, Roth JA, Tanaka N. Shao J, et al. Among authors: nishizaki m. Oncogene. 2000 Feb 10;19(6):726-36. doi: 10.1038/sj.onc.1203383. Oncogene. 2000. PMID: 10698490

7

[Recombinant adenovirus expressing wild-type p53 is antiagiogenic--implication for lung cancer gene therapy].

Fujiwara T, Nishizaki M, Tanaka N. Fujiwara T, et al. Among authors: nishizaki m. Gan To Kagaku Ryoho. 2000 Jul;27(8):1217-24. Gan To Kagaku Ryoho. 2000. PMID: 10945020 Japanese.

8

Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.

Nishizaki M, Meyn RE, Levy LB, Atkinson EN, White RA, Roth JA, Ji L. Nishizaki M, et al. Clin Cancer Res. 2001 Sep;7(9):2887-97. Clin Cancer Res. 2001. PMID: 11555607

9

Aberration of p53 and DCC in gastric and colorectal cancer.

Kataoka M, Okabayashi T, Johira H, Nakatani S, Nakashima A, Takeda A, Nishizaki M, Orita K, Tanaka N. Kataoka M, et al. Among authors: nishizaki m. Oncol Rep. 2000 Jan-Feb;7(1):99-103. Oncol Rep. 2000. PMID: 10601600

10

Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.

Jayachandran G, Sazaki J, Nishizaki M, Xu K, Girard L, Minna JD, Roth JA, Ji L. Jayachandran G, et al. Among authors: nishizaki m. Cancer Res. 2007 Nov 1;67(21):10379-88. doi: 10.1158/0008-5472.CAN-07-0677. Cancer Res. 2007. PMID: 17974981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters